Navigation Links
Phase 3 Topical Drug for Raynaud's Disease Available for Licensing/Acquisition at the J.P. Morgan Conference
Date:12/13/2012

tary topical delivery system in late-stage clinical trials targeting infectious and inflammatory skin diseases and conditions. The Company's major efforts have been focused on projects targeting Raynaud's phenomenon, nail psoriasis and actinic keratosis. In addition to historical facts or statements of current condition, this press release contains forward-looking statements within the meaning of the 'Safe Harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide the Company's current expectation or forecasts of future events. MediQuest's performance and financial results could differ materially from those reflected in these forward-looking statements due to the decisions of regulatory authorities, ability to implement its commercial plans, general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries generally. For a discussion of these and other risks and uncertainties that may affect the forward-looking statements please contact the Company. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. MediQuest undertakes no obligation to update publicly any forward-looking statement
www.mqti.com

Contact information
Joseph K. Piper
Managing Director, Point B Capital
jpiper@pointbcap.com
206-577-7223

Media Contact: Siavash Forootan MediQuest Therapeutics, 215-238-8881, sforootan@numodacapital.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE MediQuest Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
2. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
3. Insero Health Completes Phase I Trial of Novel Therapy in Patients With Drug Resistant Epilepsy
4. Unigenes Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone
5. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
6. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
7. uniQure Initiates Phase I in Acute Intermittent Porphyria
8. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
9. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
10. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
11. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015 CANTEL MEDICAL CORP. (NYSE: ... second quarter ended January 31, 2015 on Thursday, March 12 ... discuss the results at 11:00 AM ET. ... 5 to 10 minutes before the beginning of the call. ... the call will be available from Thursday, March 12, 2015 ...
(Date:3/5/2015)... -- Sanomedics, Inc. (OTC: SIMH, SIMHD) ("Sanomedics" or the "Company"), ... and acquiring cutting-edge technology, products and services announced today ... at booth # 709 at the National Association ... on March 11-13, 2015 at Caesars Palace in ... The 36 th annual NAPNAP Conference will bring ...
(Date:3/5/2015)...   ndd Medical Technologies , a leader in ... ultrasound technology, announced that its EasyOne Pro® was used ... Antonio Pulmonary Fibrosis Support Group. The clinic targeted patients ... as well as those suspected of having ILD or ... 12 square inches, EasyOne Pro provides accurate respiratory test ...
Breaking Medicine Technology:Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3
... deCODE genetics,(Nasdaq: DCGN ) today announced the ... DG071, the company,s novel small-molecule modulator,of phosphodiesterase 4 ... The compound is being developed as a new ... memory loss and cognitive deficits associated,with Alzheimer,s disease ...
... Rosetta Genomics, microRNA-based,Test, miRview(TM) Squamous, Which Differentiates Squamous From non Squamous ... Methods, A Test Based on the miRview(TM) Technology First Approved for Clinical ... ... Earlier This Year, Rosetta Genomics is Expecting to Launch miRview(TM) ...
Cached Medicine Technology:deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5
(Date:3/5/2015)... 2015 What makes a legend? In the ... almost 50 years of exceptional courtroom performance, championing big causes ... five decades of brilliant service, the Dallas Bar Association has ... will be honored at a luncheon on Tuesday, April 7, ... Avenue. Other award nominees for this year are Bob Vial, ...
(Date:3/5/2015)... TX (PRWEB) March 05, 2015 Dexas and ... new products that revolutionize how we keep our pets fed ... with their pet parents. , “Dexas and Popware™ for Pets ... and the industry has responded,” said Jeff Logan, Director of ... for carrying both food and water for your pet – ...
(Date:3/5/2015)... 05, 2015 Lakeview Regional Medical ... of the annual American Heart Association’s Heart Walk as ... Lakeview Regional Chief Executive Officer, is serving as Chairman ... March 21, 2015 at Fontainebleau State Park beginning at ... has 20 individual teams participating in this year’s event. ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Developers and ... plugins have announced a new effect preset entitled ProHalftone ... users to take advantage of combining halftone and paper ... said Christina Austin, CEO of Pixel Film Studios. “ProHalftone ... will love.” , With ProHalftone users can now generate ...
(Date:3/5/2015)... New fiber fix heat wrap, a fiber glass adhesive launched ... kind product, manufactured to withstand the highest of temperatures. This ... in the market by customers who look to mold together ... cannot be done with the usual adhesives. , A spokesperson ... our new product Fiber Fix Heat Warp and already see ...
Breaking Medicine News(10 mins):Health News:C.L. Mike Schmidt Named "Legend In Trial Law" by Dallas Bar Association 2Health News:Dexas and Popware for Pets Introduce the Snack-DuO™ Dual Chamber Bottle at Global Pet Expo. 2Health News:Dexas and Popware for Pets Introduce the Snack-DuO™ Dual Chamber Bottle at Global Pet Expo. 3Health News:Dexas and Popware for Pets Introduce the Snack-DuO™ Dual Chamber Bottle at Global Pet Expo. 4Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 3Health News:Pixel Film Studios Released ProHalftone Exclusively for Final Cut Pro X Editors 2Health News:TheHardwareCity.com Launches New Fiber Fix Heat Wrap For High Temperature Applications 2
... 25 /Xinhua-PRNewswire-FirstCall/ -- China RuiTai,International Holdings Co., ... ,the Company,), a leading producer and distributor ... of China (,PRC,), today,announced that it has ... its investor,relations campaign., China RuiTai,s primary ...
... Leaders Reveal Characteristics at National Conference, ... of the same characteristics, processes and practices. ... founder and CEO of The Beryl,Companies and ... Secret Behind,Passion, Productivity and Profit," revealed the ...
... extend to those without renal disease, study says , , ... most common bowel-cleansing preparations used by people who are ... kidney failure and long-term renal damage in otherwise healthy ... sodium phosphate solution and tablets are rare but real, ...
... 25 LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider ... announced the opening of its 75th LasikPlus(R) vision,center ... LasikPlus(R) vision,center opened this year, and the second ... opened a LasikPlus(R) vision center in Oklahoma,City in ...
... March 25 MedCom USA, Inc.,(OTC Bulletin Board: ... financial transaction solutions for the healthcare industry,owning approximately ... (OTC Bulletin Board: CDVT), announced that Card Activation ... in its lawsuit against major,retailers Barnes & Noble, ...
... March 25 Spring has officially,arrived, making it ... days and,wearing lighter, figure revealing clothing. DayTimers Experts ... Lyssie,Lakatos, RD, LD, CDN, CPT, note that planning ... Whether trying to lose weight, gain muscle ...
Cached Medicine News:Health News:China RuiTai International Holdings Retains CCG Elite for Investor Relations Services 2Health News:China RuiTai International Holdings Retains CCG Elite for Investor Relations Services 3Health News:High-Performing Healthcare Organizations Have Seven Qualities in Common 2Health News:High-Performing Healthcare Organizations Have Seven Qualities in Common 3Health News:Popular Colonoscopy Prep Solution May Pose Kidney Risks 2Health News:Popular Colonoscopy Prep Solution May Pose Kidney Risks 3Health News:LCA-Vision Announces the Opening of its 75th LasikPlus(R) Vision Center in Tulsa, Oklahoma 2Health News:MedCom Announces Card Activation Wins Significant Court Ruling 2Health News:MedCom Announces Card Activation Wins Significant Court Ruling 3Health News:Nutrition Made Simple: Organizing Wellness for Warmer Days With DayTimers 2
... The Advia 120 ... to streamline laboratory workflow ... benefits. This analyzer offers ... diagnostic assays, meeting the ...
The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis....
The XT-1800i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
The SF-3000 automated hematology analyzer can provide accurate and precise 23-parameter hematolgy results including a fully automated WBC 5-part differential from a compact space-save design....
Medicine Products: